1. Home
  2. BLTE
  3. BLTE News

Latest Belite Bio Inc (BLTE) News on October 28, 2025

BLTE

MT Newswires

2 months ago

Belite Bio to Raise $275 Million in Private Placement

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
BLTE

GlobeNewswire

2 months ago

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

BLTE

MT Newswires

5 months ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Wednesday

BLTE

MT Newswires

5 months ago

Belite Bio Says FDA Grants Breakthrough Therapy Tag to Stargardt Disease Drug

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease
BLTE

GlobeNewswire

5 months ago

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
BLTE

GlobeNewswire

5 months ago

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

We're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn
BLTE

Simply Wall St.

5 months ago

We're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn

BLTE

GuruFocus.com

5 months ago

Belite Bio Inc (BLTE) Q1 2025 Earnings Call Highlights: Strong Financial Position Amid Rising ...

BLTE

MT Newswires

5 months ago

Belite Bio Q1 Net Loss Widens

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
BLTE

GlobeNewswire

5 months ago

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
BLTE

GlobeNewswire

5 months ago

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th
BLTE

GlobeNewswire

6 months ago

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

Belite Bio to Participate in Four Upcoming Investor Conferences
BLTE

GlobeNewswire

6 months ago

Belite Bio to Participate in Four Upcoming Investor Conferences

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
BLTE

GlobeNewswire

6 months ago

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
BLTE

GlobeNewswire

6 months ago

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results
BLTE

GlobeNewswire

6 months ago

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
BLTE

GlobeNewswire

6 months ago

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

BLTE

MT Newswires

7 months ago

Belite Bio Q4 Loss Widens

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
BLTE

GlobeNewswire

7 months ago

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
BLTE

GlobeNewswire

7 months ago

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
BLTE

GlobeNewswire

8 months ago

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

Belite Bio to Participate in the Leerink Partners Global Healthcare Conference
BLTE

GlobeNewswire

8 months ago

Belite Bio to Participate in the Leerink Partners Global Healthcare Conference

BLTE

MT Newswires

8 months ago

Belite Bio Shares Phase 3 Interim Results for its Stargardt Disease Trial

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
BLTE

GlobeNewswire

8 months ago

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects

BLTE

MT Newswires

9 months ago

Belite Bio Signs Securities Purchase Deal for its American Depositary Shares, Warrants

Belite Bio Announces Registered Direct Offering of $15 Million
BLTE

GlobeNewswire

9 months ago

Belite Bio Announces Registered Direct Offering of $15 Million

Breakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE)
BLTE

Simply Wall St.

9 months ago

Breakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE)

Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
BLTE

GlobeNewswire

a year ago

Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007

BLTE

MT Newswires

a year ago

Belite Bio Q3 Net Loss Narrows

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
BLTE

GlobeNewswire

a year ago

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
BLTE

GlobeNewswire

a year ago

Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results

BLTE

MT Newswires

a year ago

Belite Bio Raises $28.8 Million After Warrants Exercised

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
BLTE

GlobeNewswire

a year ago

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
BLTE

GlobeNewswire

a year ago

Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting

Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit
BLTE

GlobeNewswire

a year ago

Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
BLTE

GlobeNewswire

a year ago

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Here's Why We're Not At All Concerned With Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
BLTE

Simply Wall St.

a year ago

Here's Why We're Not At All Concerned With Belite Bio's (NASDAQ:BLTE) Cash Burn Situation

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
BLTE

GlobeNewswire

a year ago

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
BLTE

GlobeNewswire

a year ago

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
BLTE

GlobeNewswire

a year ago

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
BLTE

GlobeNewswire

a year ago

Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease

Belite Bio to Participate in Three Upcoming Investor Conferences
BLTE

GlobeNewswire

a year ago

Belite Bio to Participate in Three Upcoming Investor Conferences

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
BLTE

GlobeNewswire

a year ago

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer

Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
BLTE

GlobeNewswire

a year ago

Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
BLTE

GlobeNewswire

a year ago

Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
BLTE

GlobeNewswire

a year ago

Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results

Belite Bio to Present at the JonesHealthcare Seaside Summit
BLTE

GlobeNewswire

a year ago

Belite Bio to Present at the JonesHealthcare Seaside Summit

Estimating The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)
BLTE

Simply Wall St.

a year ago

Estimating The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)

BLTE

MT Newswires

a year ago

Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
BLTE

GlobeNewswire

a year ago

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
BLTE

GlobeNewswire

a year ago

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

BLTE

MT Newswires

a year ago

Belite Bio's Q1 Loss Narrows

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
BLTE

GlobeNewswire

a year ago

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
BLTE

GlobeNewswire

a year ago

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
BLTE

GlobeNewswire

a year ago

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
BLTE

GlobeNewswire

a year ago

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
BLTE

GlobeNewswire

a year ago

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
BLTE

GlobeNewswire

a year ago

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

BLTE

MT Newswires

2 years ago

Belite Bio Unveils Plan to Offer 651,380 American Depository Shares

Belite Bio Announces $25 Million Registered Direct Offering
BLTE

GlobeNewswire

2 years ago

Belite Bio Announces $25 Million Registered Direct Offering

Does Belite Bio (BLTE) Have the Potential to Rally 41.14% as Wall Street Analysts Expect?
BLTE

Zacks

2 years ago

Does Belite Bio (BLTE) Have the Potential to Rally 41.14% as Wall Street Analysts Expect?

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
BLTE

GlobeNewswire

2 years ago

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan

Here's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
BLTE

Simply Wall St.

2 years ago

Here's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situation

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
BLTE

GlobeNewswire

2 years ago

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
BLTE

GlobeNewswire

2 years ago

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
BLTE

GlobeNewswire

2 years ago

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
BLTE

GlobeNewswire

2 years ago

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
BLTE

GlobeNewswire

2 years ago

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

BLTE

Argus Research

2 years ago

Daily – Vickers Top Buyers & Sellers for 02/01/2024

Should You Invest in Perion Network (PERI) Based on Bullish Wall Street Views?
BLTE

Zacks

2 years ago

Should You Invest in Perion Network (PERI) Based on Bullish Wall Street Views?

If You Invested $10,000 in Medical Properties Trust in 2014, This Is How Much You Would Have Today
BLTE

Motley Fool

2 years ago

If You Invested $10,000 in Medical Properties Trust in 2014, This Is How Much You Would Have Today

MAG Silver (MAG) Reports Solid Production at Juanicipio
BLTE

Zacks

2 years ago

MAG Silver (MAG) Reports Solid Production at Juanicipio

3 Struggling Stocks That Can Rise Between 83% and 264%, According to Wall Street
BLTE

Motley Fool

2 years ago

3 Struggling Stocks That Can Rise Between 83% and 264%, According to Wall Street

Shutterstock Inc Executive Chairman and 10% Owner Jonathan Oringer Sells 24,197 Shares
BLTE

GuruFocus.com

2 years ago

Shutterstock Inc Executive Chairman and 10% Owner Jonathan Oringer Sells 24,197 Shares

First Financial Bancorp (FFBC) Tops Q4 Earnings Estimates
BLTE

Zacks

2 years ago

First Financial Bancorp (FFBC) Tops Q4 Earnings Estimates

NuStar Energy L.P. Declares Fourth Quarter 2023 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions
BLTE

Business Wire

2 years ago

NuStar Energy L.P. Declares Fourth Quarter 2023 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions

WesBanco Declares Quarterly Cash Dividend upon Its Perpetual Preferred Stock
BLTE

PR Newswire

2 years ago

WesBanco Declares Quarterly Cash Dividend upon Its Perpetual Preferred Stock

Here's What Key Metrics Tell Us About Lakeland Financial (LKFN) Q4 Earnings
BLTE

Zacks

2 years ago

Here's What Key Metrics Tell Us About Lakeland Financial (LKFN) Q4 Earnings

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks
BLTE

StockStory

2 years ago

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks

BLTE

Associated Press Finance

2 years ago

City Holding: Q4 Earnings Snapshot

City Holding Company Announces Record Annual Earnings
BLTE

Business Wire

2 years ago

City Holding Company Announces Record Annual Earnings

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest
BLTE

StockStory

2 years ago

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water
BLTE

Zacks

2 years ago

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Pinterest and First Majestic Silver have been highlighted as Zacks Bull and Bear of the Day
BLTE

Zacks

2 years ago

Pinterest and First Majestic Silver have been highlighted as Zacks Bull and Bear of the Day

Zacks Industry Outlook Highlights American Water Works, California Water Service Group, SJW Group and Consolidated Water
BLTE

Zacks

2 years ago

Zacks Industry Outlook Highlights American Water Works, California Water Service Group, SJW Group and Consolidated Water

Best Value Stocks to Buy for January 23rd
BLTE

Zacks

2 years ago

Best Value Stocks to Buy for January 23rd

Agilysys Inc (AGYS) Reports Record Revenue Growth in Q3 Fiscal 2024
BLTE

GuruFocus.com

2 years ago

Agilysys Inc (AGYS) Reports Record Revenue Growth in Q3 Fiscal 2024

Here is What to Know Beyond Why Pioneer Natural Resources Company (PXD) is a Trending Stock
BLTE

Zacks

2 years ago

Here is What to Know Beyond Why Pioneer Natural Resources Company (PXD) is a Trending Stock

Xerox Holdings Corporation Plans Webcast to Discuss 2023 Fourth-Quarter and Full-Year Results
BLTE

Business Wire

2 years ago

Xerox Holdings Corporation Plans Webcast to Discuss 2023 Fourth-Quarter and Full-Year Results

These Stocks Moved the Most Today: Spirit Airlines, JetBlue, Schwab, Rivian, Boeing, SolarEdge, Boeing, Impinj, and More
BLTE

Barrons.com

2 years ago

These Stocks Moved the Most Today: Spirit Airlines, JetBlue, Schwab, Rivian, Boeing, SolarEdge, Boeing, Impinj, and More

Getty Realty Corp. Announces 2023 Dividend Tax Treatment
BLTE

GlobeNewswire

2 years ago

Getty Realty Corp. Announces 2023 Dividend Tax Treatment

Werner (WERN) Board Appoints Nathan Meisgeier as President
BLTE

Zacks

2 years ago

Werner (WERN) Board Appoints Nathan Meisgeier as President

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions
BLTE

Business Wire

2 years ago

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?
BLTE

Simply Wall St.

2 years ago

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?

Abbott, Tandem launch new hybrid closed-loop insulin delivery system
BLTE

MedTech Dive

2 years ago

Abbott, Tandem launch new hybrid closed-loop insulin delivery system

Is H&E Equipment (HEES) a Solid Growth Stock? 3 Reasons to Think "Yes"
BLTE

Zacks

2 years ago

Is H&E Equipment (HEES) a Solid Growth Stock? 3 Reasons to Think "Yes"

New Strong Buy Stocks for January 3rd
BLTE

Zacks

2 years ago

New Strong Buy Stocks for January 3rd

Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
BLTE

GlobeNewswire

2 years ago

Galapagos signs agreement to transfer Jyseleca® business to Alfasigma

Should Value Investors Buy H&E Equipment Services (HEES) Stock?
BLTE

Zacks

2 years ago

Should Value Investors Buy H&E Equipment Services (HEES) Stock?

Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
BLTE

Business Wire

2 years ago

Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference

Share on Social Networks: